Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-390-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July - October 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- See details in section : Principles of method if other than guideline.
- Qualifier:
- according to guideline
- Guideline:
- other: European Economic Community (EEC). Directive 2000/32/EC, Part B.
- Deviations:
- yes
- Remarks:
- See details in section: Principles of method if other than guideline.
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Health, Labour and Welfare, Ministry of Economy. Trade and Industry and Ministry of the Environment.
- Deviations:
- yes
- Remarks:
- See details in section: Principles of method if other than guideline.
- Principles of method if other than guideline:
- REMARK From deviations :
The highest dose level tested (100 micrograms/ml) for the 24 and 48 h exposure time is determined by the solubility in the culture medium. Since the test article was tested at the highest dose level possible in this test system, restricted by the solubility in the solvent, this deviation of testing concentrations beyond the limit of solubility has no effect on the results of this study. - GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- -
- EC Number:
- 473-390-7
- EC Name:
- -
- Cas Number:
- 1093615-61-2
- Molecular formula:
- C7F15NO
- IUPAC Name:
- 2,2,3,3,5,5,6,6-octafluoro-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)morpholine; 2,2,3,3,5,5,6,6-octafluoro-4-(1,1,2,2,3,3,3-heptafluoropropyl)morpholine
- Reference substance name:
- MTDID 7145
- IUPAC Name:
- MTDID 7145
- Details on test material:
- - Name of test material (as cited in study report): MTDID 7145
- Substance type: clear colorless liquid
- Physical state: liquid
- Analytical purity: ~94.5%
- Impurities (identity and concentrations): NA
- Lot/batch no.: Batch 142072:43
- Expiration date of the lot/batch: 30 December 2007
- Stability under test conditions: Stable at higher temperatures to 200 degrees C, maximum duration 24 hours. Stable in ethanol for atleast 96 hours.
- Storage condition of test material: At room temperature in the dark
- Other: pH: 7.2.
- Specific Gravity: 1.8
Constituent 1
Constituent 2
Method
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: Peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- - Type and identity of media: cultured medium consdidted of RPMI 1640 medium, supplemented with 20 (v/v) heat-inactivated (56 degrees C); 30 min) foetal calf serum, L-glutamine(2 nM), penicillin/streptomycin (50 U/ml and 50 micrograms/mL respectively) and 30 U/mL heparin.
- Properly maintained: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 (9000 x G supernatant)
- Test concentrations with justification for top dose:
- Dose-Range finding study: 1,3, 10, 33 and 100 micrograms/ml. Without S9 mix: 10, 33 and 100 micrograms/ml culture medium. With S9-mix: 10,33,66 and 100 micrograms/ml culture medium.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: excellent solubility characteristics
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Solvent for positive controls: Hank's Balanced Salt Soultion (HBSS) without calcium and magnesium.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Exposure duration: 3 hours, 24 hours, 48 hours
- Fixation time (start of exposure up to fixation or harvest of cells):24 hours/48 hours
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- Considered a positive response if a) It iduced a dose-related statistically significant increase in the frequencies of the number of cells with in chromosome abberations. b) A statistically significant and biologically relevant increase in the frequency of the number of cells with chromosome abberations was observed in the absence of a clear dose-response relathionship.
- Statistics:
- Chi-squared test, one-sided, p <0.5
Results and discussion
Test results
- Species / strain:
- mammalian cell line, other: human peripheral lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- negative with and without metabolic activation up to 100 micrograms/mL
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- but tested up to limit concentrations (100 micrograms/mL)
- Vehicle controls validity:
- valid
- Positive controls validity:
- other: yes, mitomycin-C (without metabolic activation).
- Remarks on result:
- other: strain/cell type:
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test article is not clastogenic in human lymphocytes under the experimental conditions described in the report. - Executive summary:
The purpose of this study was to evaluate the ability of the test article to induce chromosome aberrations in cultured peripheral human lymphocytes. The most recent OECD Guidelines (OECD 473, 1997) were employed. In the first cytogenetic assay, the test article was tested up to 100 ug/mL for a 3-hour exposure with a 24-hour fixation time in the absence and presence of S-9 mix (1.8% v/v).The test article precipitated in the culture medium at this dose level. In the second cytogenetic assay, the test substance was tested up to 100 ug/mL for 24-hours and 48-hours of continuous exposure time with 24-hour and 48-hour fixation times in the absence of S9-mix. In the presence of S9-mix, the test material was tested up to 100 ug/mL for a 3-hour exposure time with a 48-hour fixation time. Positive control chemicals mitomycin C and cyclophosphamide both produced a statistically significant increase in the incidence of cells with chromosome aberrations indicating that the test conditions were adequate and that the metabolic activation system functioned properly. The test article did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations in the absence and presence of S9-mix in two independently repeated experiments. No effects of the test article on the number of polyploid cells and cells with endoreduplicated chromosomes were observed in either the absence or presence of S9-mix. Therefore, it can be concluded that the test article does not disturb mitotic processes and cell cycle progression and does not induce numerical chromosome aberrations under these experimental conditions. It is concluded that the test article is not clastogenic in human lymphocytes under the conditions described in this report.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
